Follow
Lisa H. Butterfield
Lisa H. Butterfield
Verified email at ucsf.edu
Title
Cited by
Cited by
Year
B cells and tertiary lymphoid structures promote immunotherapy response
BA Helmink, SM Reddy, J Gao, S Zhang, R Basar, R Thakur, K Yizhak, ...
Nature 577 (7791), 549-555, 2020
11212020
Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial
HA Tawbi, M Burgess, V Bolejack, BA Van Tine, SM Schuetze, J Hu, ...
The Lancet Oncology 18 (11), 1493-1501, 2017
8332017
Induction of CD8+ T-cell responses against novel glioma–associated antigen peptides and clinical activity by vaccinations with α-type 1 polarized dendritic cells and …
H Okada, P Kalinski, R Ueda, A Hoji, G Kohanbash, TE Donegan, ...
Journal of clinical oncology 29 (3), 330, 2011
6082011
A phase I/II trial testing immunization of hepatocellular carcinoma patients with dendritic cells pulsed with four α-fetoprotein peptides
LH Butterfield, A Ribas, VB Dissette, Y Lee, JQ Yang, P De la Rocha, ...
Clinical Cancer Research 12 (9), 2817-2825, 2006
5312006
Immunotherapy of cancer in 2012
JM Kirkwood, LH Butterfield, AA Tarhini, H Zarour, P Kalinski, S Ferrone
CA: a cancer journal for clinicians 62 (5), 309-335, 2012
5172012
T-cell responses to HLA-A* 0201 immunodominant peptides derived from α-fetoprotein in patients with hepatocellular cancer
LH Butterfield, A Ribas, WS Meng, VB Dissette, S Amarnani, HT Vu, ...
Clinical Cancer Research 9 (16), 5902-5908, 2003
4302003
A comparison of gene transfer methods in human dendritic cells.
JF Arthur, LH Butterfield, MD Roth, LA Bui, SM Kiertscher, R Lau, ...
Cancer gene therapy 4 (1), 17-25, 1997
4151997
Current developments in cancer vaccines and cellular immunotherapy
A Ribas, LH Butterfield, JA Glaspy, JS Economou
Journal of clinical oncology 21 (12), 2415-2432, 2003
4012003
Ipilimumab plus sargramostim vs ipilimumab alone for treatment of metastatic melanoma: a randomized clinical trial
FS Hodi, S Lee, DF McDermott, UN Rao, LH Butterfield, AA Tarhini, ...
Jama 312 (17), 1744-1753, 2014
3602014
Determinant spreading associated with clinical response in dendritic cell-based immunotherapy for malignant melanoma
LH Butterfield, A Ribas, VB Dissette, SN Amarnani, HT Vu, D Oseguera, ...
Clinical Cancer Research 9 (3), 998-1008, 2003
3122003
Immune monitoring of the circulation and the tumor microenvironment in patients with regionally advanced melanoma receiving neoadjuvant ipilimumab
AA Tarhini, H Edington, LH Butterfield, Y Lin, Y Shuai, H Tawbi, C Sander, ...
PloS one 9 (2), e87705, 2014
2882014
Baseline circulating IL-17 predicts toxicity while TGF-β1 and IL-10 are prognostic of relapse in ipilimumab neoadjuvant therapy of melanoma
AA Tarhini, H Zahoor, Y Lin, U Malhotra, C Sander, LH Butterfield, ...
Journal for immunotherapy of cancer 3, 1-6, 2015
2742015
Soluble PD-L1 as a Biomarker in Malignant Melanoma Treated with Checkpoint BlockadeSoluble PD-L1 in Melanoma
J Zhou, KM Mahoney, A Giobbie-Hurder, F Zhao, S Lee, X Liao, S Rodig, ...
Cancer immunology research 5 (6), 480-492, 2017
2662017
Next generation of immunotherapy for melanoma
JM Kirkwood, AA Tarhini, MC Panelli, SJ Moschos, HM Zarour, ...
Journal of Clinical Oncology 26 (20), 3445-3455, 2008
2652008
Generation of human T-cell responses to an HLA-A2. 1-restricted peptide epitope derived from α-fetoprotein
LH Butterfield, A Koh, W Meng, CM Vollmer, A Ribas, V Dissette, E Lee, ...
Cancer research 59 (13), 3134-3142, 1999
2551999
Cancer vaccines
LH Butterfield
Bmj 350, 2015
2422015
Genetic immunization for the melanoma antigen MART-1/Melan-A using recombinant adenovirus-transduced murine dendritic cells
A Ribas, LH Butterfield, WH McBride, SM Jilani, LA Bui, CM Vollmer, ...
Cancer Research 57 (14), 2865-2869, 1997
2351997
α-Fetoprotein-specific genetic immunotherapy for hepatocellular carcinoma
CM Vollmer Jr, FC Eilber, LH Butterfield, A Ribas, VB Dissette, A Koh, ...
Cancer Research 59 (13), 3064-3067, 1999
2321999
Dendritic cell–based cancer vaccines
PM Santos, LH Butterfield
The Journal of Immunology 200 (2), 443-449, 2018
2292018
Novel technologies and emerging biomarkers for personalized cancer immunotherapy
J Yuan, PS Hegde, R Clynes, PG Foukas, A Harari, TO Kleen, P Kvistborg, ...
Journal for immunotherapy of cancer 4, 1-25, 2016
2252016
The system can't perform the operation now. Try again later.
Articles 1–20